ALGS
Aligos Therapeutics
$4.08
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame ALGS today
- Market cap
- $25.25M
- P/E (TTM)
- -0.3
- EV / FCF
- 0.0
- Gross margin
- 100%
- EV / Sales
- -0.1
- ROIC
- -167.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.98
- 52wk High
- $13.69
Growth
Revenue and earnings trend for ALGS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALGS
Is Aligos Therapeutics a good buy?
No. Aligos Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of ALGS?
Aligos Therapeutics's market capitalization is $25.25M.
What is the P/E ratio for ALGS stock?
Aligos Therapeutics's current P/E ratio is -0.3.
What is the 52-week high for ALGS stock?
The 52-week high for Aligos Therapeutics is $13.69. The current close of $4.08 is 70.2% below that high.
What is the 52-week low for ALGS stock?
The 52-week low for Aligos Therapeutics is $3.98. The current close of $4.08 is 2.5% above that low.
Does ALGS stock pay dividends?
Aligos Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALGS?
Aligos Therapeutics's Debt / Equity ratio is 0.14.